Skip to content

Menu

Company
- PURPOSE
- ABOUT
- TEAM
- NEWS
- CONTACT
Platform
- FLECS TECHNOLOGY
- PUBLICATIONS
Mechanomedicine
- MECHANICAL DISEASES
- PIPELINE
For Researchers
- FLECS WELL-PLATE PRODUCTS
- DISCOVERY & SCREENING SERVICES

Forcyte’s Cardiac Tissuoid assay is now available

Posted on May 7, 2019May 7, 2019 by forcyte

Posted in Uncategorized

Leave a Reply Cancel reply

Your email address will not be published.

Comment

Name

Email

Website

Δ

Search for:

Recent Posts

Forcyte awarded Phase 2 SBIR by NIH / NCATS to develop pseudo-3D contractile “tissuoid” assay enabling study of coordinated cell contractions and tachyphylaxis
New App Note covering FLECS Technology in collaboration with Molecular Devices is now available:
Forcyte’s Cardiac Tissuoid assay is now available
Forcyte Bio to participate in Innovation AveNEW for Startups Showcase at SLAS 2019
Forcyte awarded NIH funding for a FLECS-based uterine contractility model

Recent Comments

Archives

September 2019
May 2019
January 2019
July 2018
April 2018
March 2018
November 2017

Categories

Conferences
Funding
New Materials
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Copyright © 2017 Forcyte Biotechnologies, Inc